Sensorineural hearing loss

Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update

Retrieved on: 
Monday, November 20, 2023

WHITE BEAR LAKE, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) --  Envoy Medical, Inc. (“Envoy Medical”) (NASDAQ: COCH), a hearing health company, today is providing a business update and its financial results for the quarter ended September 30, 2023. The Company will host a virtual fireside chat event on December 7, which will cover a range of topics, including introductions to the technology, financial and clinical aspects of the business, as well as potential participation from cochlear implant key opinion leaders.

Key Points: 
  • WHITE BEAR LAKE, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Envoy Medical, Inc. (“Envoy Medical”) ( NASDAQ: COCH ), a hearing health company, today is providing a business update and its financial results for the quarter ended September 30, 2023.
  • Envoy Medical is a medical technology company specializing in revolutionary “fully” or “totally” implanted hearing devices.
  • We believe these accomplishments put Envoy Medical on track to advance our strategic plan over the next several years.
  • As a newly listed Company on the Nasdaq Stock Exchange, Envoy Medical will host an introductory educational virtual event on December 7.

Desktop Health™ Announces Hannover Medical School Has Implanted the First Adult Custom Ear Implant with Drug Release Benefits Manufactured on the 3D-Bioplotter®

Retrieved on: 
Tuesday, October 31, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231031818640/en/
    The ENT clinic at Hannover Medical School (MHH) in Germany has used its Desktop Health 3D-Bioplotter to produce a customized ear implant with drug release benefits for implantation in an adult patient.
  • A growing number of parts bioprinted on the 3D-Bioplotter are being used in patients.
  • “Our entire team celebrates this important accomplishment by the Hannover Medical School ENT clinic, which has been years in the making,” said Ric Fulop, Founder and CEO of Desktop Metal.
  • The MHH ENT Clinic is internationally renowned for the world's largest cochlear implant program for the care of hearing-impaired patients.

Genome Insight Announces Upcoming Presentations at 2023 NORD Breakthrough Summit on Enhancing Diagnostic Precision for Sensorineural Hearing Loss

Retrieved on: 
Monday, October 16, 2023

Genome Insight is set to unveil clinical research findings on the genetic foundation of rare diseases at the 2023 NORD Rare Disease & Orphan Products Breakthrough Summit (2023 NORD Breakthrough Summit) in Washington, DC.

Key Points: 
  • Genome Insight is set to unveil clinical research findings on the genetic foundation of rare diseases at the 2023 NORD Rare Disease & Orphan Products Breakthrough Summit (2023 NORD Breakthrough Summit) in Washington, DC.
  • Genome Insight will present the results of a collaborative clinical study on Whole Genome Sequencing (WGS) in rare diseases, specifically focusing on sensorineural hearing loss (SNHL).
  • With a WGS pipeline exclusively designed for rare diseases (‘RareVision’), Genome Insight has fostered its collaborations with global medical institutions.
  • "We are thrilled to present our groundbreaking rare disease research at the esteemed 2023 NORD Breakthrough Summit," stated June-Young Koh, M.D./Ph.D.

Mogrify Extends Series A Financing to $46 Million USD

Retrieved on: 
Monday, October 2, 2023

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing, bringing the total raised to $46 million USD in this round.

Key Points: 
  • Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing, bringing the total raised to $46 million USD in this round.
  • The funding will support further advancement of Mogrify’s pipeline of in vivo reprogramming therapies through pre-clinical translation, continued platform optimization, and facilitation of new and existing biopharma collaborations.
  • Proceeds from the financing will be used to advance Mogrify’s pipeline of in vivo reprogramming therapies, delivering the milestones necessary to facilitate a Series B fundraise in 2024/25 and subsequent progression of a lead program into first-in-human studies.
  • Mogrify’s proprietary platform technologies enable systematic identification of the key transcriptomic and epigenetic cell switches required to control human cell fate.

Global Hearing Diagnostic Devices and Equipment Market Report 2023-2032: Strategies for Thriving in the Hearing Diagnostic Devices Market - AI, Wireless Integration, and More - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 10, 2023

The "Hearing Diagnostic Devices and Equipment Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hearing Diagnostic Devices and Equipment Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering.
  • Market-trend-based strategies for the hearing diagnostic devices and equipment market include focus on adoption of artificial intelligence, remote hearing screening, integration of wireless technology with hearing diagnostic devices, digital otoscope, rising investments and increasing collaborations.
  • The hearing diagnostic devices and equipment market is also segmented by indication into conductive hearing loss, sensorineural hearing loss, combination hearing loss and other indications.
  • The sensorineural hearing loss market was the largest segment of the hearing diagnostic devices and equipment market segmented by indication, accounting for 45.8% of the total in 2022
    The global hearing diagnostic devices and equipment market is fairly fragmented, with a large number of players.

Hearing Implants Global Market Outlook Report 2023: Historic Market Revenues from 2020-2021, Estimates for 2022, and CAGR Projections through 2027

Retrieved on: 
Tuesday, May 2, 2023

In this report, the market has been segmented based on by product, patient type, type of hearing loss, and geographic region.

Key Points: 
  • In this report, the market has been segmented based on by product, patient type, type of hearing loss, and geographic region.
  • The report provides an overview of the global hearing implant market and analyzes market trends.
  • Hearing implants are mainly recommended for people with severe or profound hearing loss who have not benefitted adequately from the sound amplification of hearing aids.
  • In this report, the global market for hearing implants is segmented based on product, patient type, type of hearing loss and geographical region.

Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Friday, March 10, 2023

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2022.

Key Points: 
  • Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2022.
  • MS in characterized by demyelination, stripping axons of the myelin sheaths that support neuronal signal conduction and axonal survival.
  • Net Loss: Net loss was $17.4 million for the three months ended December 31, 2022, as compared to $21.5 million for the comparable period of 2021.
  • Net loss was $81.6 million for the full year ended December 31, 2022, as compared to $84.7 million for the comparable period of 2021.

Global Hearing Implants Market Outlook to 2027: Featuring Cochlear, Demant, Envoy Medical, Med-El Medical Electronics and Medtronic Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 28, 2023

There is no upper age limit for the implantation of hearing implants, although some preliminary evaluations are required for older adults.

Key Points: 
  • There is no upper age limit for the implantation of hearing implants, although some preliminary evaluations are required for older adults.
  • Hearing implants can be used for bilateral and unilateral hearing loss.
  • In this report, the global market for hearing implants is segmented based on product, patient type, type of hearing loss and geographical region.
  • The hearing implant market by product is categorized into four types of implants: cochlear, bone conduction, middle ear and auditory brainstem.

MED-EL Presents: World Cochlear Implant Day 2023 - Over 45 years of major technological advances that enhance hearing and quality of life

Retrieved on: 
Friday, February 24, 2023

World Cochlear Implant Day pays tribute to the tremendous technological developments since the modern cochlear implant was first invented 45 years ago.

Key Points: 
  • World Cochlear Implant Day pays tribute to the tremendous technological developments since the modern cochlear implant was first invented 45 years ago.
  • While the initial CIs required bulky body-worn audio processors, they revolutionized the way individuals with sensorineural hearing loss could experience the world by restoring a sense of sound and speech.
  • The continuous improvements in technology and design offer people of all ages with hearing loss new quality of life.
  • MED-EL offers valuable information on its website , including an overview of the various types of hearing loss and a free online hearing test that can help identify a potential hearing loss.

MED-EL Presents: World Cochlear Implant Day 2023 - Over 45 years of major technological advances that enhance hearing and quality of life

Retrieved on: 
Friday, February 24, 2023

World Cochlear Implant Day pays tribute to the tremendous technological developments since the modern cochlear implant was first invented 45 years ago.

Key Points: 
  • World Cochlear Implant Day pays tribute to the tremendous technological developments since the modern cochlear implant was first invented 45 years ago.
  • While the initial CIs required bulky body-worn audio processors, they revolutionized the way individuals with sensorineural hearing loss could experience the world by restoring a sense of sound and speech.
  • The continuous improvements in technology and design offer people of all ages with hearing loss new quality of life.
  • MED-EL offers valuable information on its website , including an overview of the various types of hearing loss and a free online hearing test that can help identify a potential hearing loss.